Join to view full profile
259 Monroe AvenueRochester, NY 14607
Phone+1 585-545-7200
Fax+1 585-244-6456
Dr. Valenti is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Valenti is a clinical virologist/ infectious disease specialist based in Rochester, NY. His M.D. degree is from the Medical College of Wisconsin and he completed a fellowship in infectious diseases at the University of Rochester Medical Center. His professional interests include HIV prevention and treatment, LGBT health, emerging infectious diseases, sexual health. He has published extensively in these areas.
He is the co-founder of Community Health Network HIV Clinic (1989), now Trillium Health, a Federally Qualified Heath Center in Rochester, NY.
His has received numerous honors over the course of his career; in 2025, the Liberty Medal, New York State's highest civilian honor, for his 45 year contributions to HIV treatment, research and policy.
Education & Training
University of Rochester Medical CenterFellowship, Infectious Disease, 1975 - 1977- University of Rochester Medical CenterResidency, Internal Medicine, 1974 - 1975
Rochester Regional Health/Rochester General HospitalResidency, Internal Medicine, 1972 - 1974
Medical College of WisconsinClass of 1972
Certifications & Licensure
FL State Medical License 2015 - 2028
NY State Medical License 1973 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Liberty Medal New York State Senate, 2025
- Albert D. Kaiser Medal Rochester Academy of Medicine, 2019
- Alum of the Year Medical College of Wisconsin, 2017
Publications & Presentations
PubMed
- 11 citationsClinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an ...Dima Dandachi, Cindy Garris, David Richardson, Gary Sinclair, Doug Cunningham
Open Forum Infectious Diseases. 2025-05-01 - 1 citationsReal world community-based HIV Rapid Start Antiretroviral with B/F/TAF versus prior models of antiretroviral therapy start - the RoCHaCHa study, a pilot study.William Valenti, Jacob Scutaru, Michael Mancenido, Ashley Zuppelli, Alexandra Danforth
AIDS Research and Therapy. 2024-07-10 - 29 citationsWillingness to Take PrEP for HIV Prevention: The Combined Effects of Race/Ethnicity and Provider Trust.Amy Braksmajer, Theresa Marie Fedor, Shaw-Ree Chen, Roberto Corales, Sally Holt
AIDS Education and Prevention. 2018-02-01
Books/Book Chapters
Authored Content
- Monkeypox Summary: IDWeek 2022October 2022
- COVID-19'S Cornering of IAS 2020July 2020
- COVID-19'S Cornering of IAS 2020July 2020
Press Mentions
Pioneering HIV Researcher Dr. William Valenti Retiring From Trillium HealthOctober 2nd, 2025- Many Clinics Await Flu Vaccine: ‘We Want to Be Prepared’August 18th, 2022
- 56% Clinicians Now Plan to Attend in-Person ConferencesMay 4th, 2022
Professional Memberships
- Fellow
- Chair, Infectious Diseases Committee
External Links
- Dr Bill Media LLChttp://www.drbillvalenti.com
- Facebookhttps://www.facebook.com/BillValentiMD/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
